CC - The Chemours Company
15.80 -0.01 (-0.06%)
After hours: 5:06PM EDT
Chart Events
Momentum
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 15.26 |
| Open | 15.34 |
| Bid | 15.17 x 1000 |
| Ask | 15.87 x 800 |
| Day's Range | 15.20 - 15.97 |
| 52 Week Range | 7.02 - 20.73 |
| Volume | 1,461,000 |
| Avg. Volume | 2,218,693 |
| Market Cap | 2.596B |
| Beta (5Y Monthly) | 2.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 |
| Earnings Date | Jul 30, 2020 |
| Forward Dividend & Yield | 1.00 (6.39%) |
| Ex-Dividend Date | May 14, 2020 |
| 1y Target Est | 15.30 |
Fair Value
Related Research
- Insider Monkey
Did Hedge Funds Make The Right Call On The Chemours Company (CC) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
- PR Newswire
Chemours Announces Dates for Second Quarter 2020 Earnings Release and Webcast Conference Call
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced it will release second quarter 2020 financial results after market close on Thursday, July 30, 2020. The company will conduct its second quarter 2020 webcast conference call on Friday, July 31, 2020 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.
- Insider Monkey
Should Investors Buy the Dip in Chemours (CC) Stock?
If you are looking for the best ideas for your portfolio you may want to consider some of Greenlight Capital's top stock picks. Greenlight Capital, an investment management firm, is bullish on Chemours Co (NYSE:CC) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its investment […]
- Zacks
Chemours Gets EPA Nod for Glyclean Cleaner for Coronavirus
Chemours (CC) is working closely with customers to ensure that it offers products required for slowing and limiting the spread of the coronavirus.
- PR Newswire
U.S. Environmental Protection Agency Approves Glycleanâ„¢ Hard Surface Cleaner as an Effective Disinfectant Against the Virus that Causes COVID-19
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the U.S. Environmental Protection Agency (EPA), has approved Glycleanâ„¢ Hard Surface Cleaner for use against SARS-COV-2, the virus that causes COVID-19. When Glyclean AM is formulated at appropriate concentrations into cleaning and disinfecting products, they too can be effective against the SARS-COV-2 virus and help prevent the spread of the novel coronavirus.
- Thomson Reuters StreetEvents
Edited Transcript of CC.N earnings conference call or presentation 6-May-20 12:30pm GMT
Q1 2020 Chemours Co Earnings Call
- Insider Monkey
Buy Chemours Co (CC) Stock for Massive Upside Ahead
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned -19.6% in the same quarter. You should check out Miller […]
- Insider Monkey
Hedge Funds Getting Bullish On The Chemours Company (CC)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- Zacks
Why Is Chemours (CC) Up 20.1% Since Last Earnings Report?
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Greenlight Capital Exits General Motors, Cuts Chemours
Firm's largest sales of the 1st quarter Continue reading...
- Moody's
E.I. du Pont de Nemours and Company -- Moody's rates E.I. du Pont de Nemours and Company's (Corteva's) new notes A3
Moody's Investors Service, ("Moody's") assigned A3 ratings to E.I. du Pont de Nemours and Company's (EID's) proposed senior unsecured notes. Roughly half of the proceeds from the debt issuance are expected to be used to prepay a portion of the company's unfunded pension liability, leaving the company's gross adjusted leverage unchanged for this portion of the issuance, with the balance of proceeds held in cash to shore up liquidity and serving as an offset to seasonal working capital needs, which tend to be very large and peak at about $4.0 billion. The outlook on the ratings is stable.
- Insider Monkey
McIntyre Partnerships 1Q20 Commentary: Long Chemours [Analysis]
McIntyre Partnerships commentary for the first quarter ended March 31, 2020, discussing how the current crisis will likely impact Chemours (NYSE:CC)’s near-term earnings. Performance Review - FY 2019 Through Q1 2020, McIntyre Partnerships returned approx. -56% gross and net. This compares to S&P 500, S&P 600, and Russell 2000 returns including dividends of -20%, -33%, […]
- Simply Wall St.
The Chemours Company Just Beat EPS By 39%: Here's What Analysts Think Will Happen Next
It's been a good week for The Chemours Company (NYSE:CC) shareholders, because the company has just released its...
- Motley Fool
The Chemours Company (CC) Q1 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Chemours Company First quarter Earnings Call. Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operations and the other risks and uncertainties described in the documents Chemours has filed with the SEC.
- Motley Fool
Why Chemours Stock Jumped 13% Today
Shares of specialty chemical company Chemours (NYSE: CC) jumped nearly 14% as trading opened for the day. Although the company's titanium coatings business did well (sales were up 10% in the segment), its other two divisions (fluoroproducts and chemical solutions)Â saw year-over-year sales declines.
- Zacks
Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1
Decline volumes in the Fluoroproducts unit and lower global average prices across all segments hurt Chemours' (CC) Q1 sales.
- Zacks
Chemours (CC) Tops Q1 Earnings Estimates
Chemours (CC) delivered earnings and revenue surprises of 39.22% and -2.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- MarketWatch
Teflon maker Chemours tops Q1 sales and profit views, withdraws guidance
Shares of Chemours Co. gained more than 5% in the extended session Tuesday after the chemicals company reported first-quarter profit and sales above Wall Street expectations and said it planned to cut costs amid slower demand with the coronavirus pandemic. Chemours said it earned $100 million, or 61 cents a share, in the quarter, compared with $94 million, or 55 cents a share, in the year-ago period. Adjusted for one-time items, the company earned $118 million, or 71 cents a share, compared with 63 cents a share a year ago. Sales fell to $1.3 billion from $1.4 billion a year ago. Analysts polled by FactSet expected the company to report adjusted profit of 46 cents a share on sales of $1.3 billion. Chemours said all of its plants are operating "with minimal impact from COVID-19." To weather the slackened demand, however, the company said it aims to cut 2020 costs by $160 million and its capital expenditure plan by by $125 million to $275 million. Chemours said it had "ample" liquidity with no debt due in the near term. The company withdrew its 2020 guidance due to "current demand uncertainty, driven by COVID-19." Shares of Chemours had ended the regular trading day up nearly 12%.
- Motley Fool
Why Shares of Chemours Are Soaring Today
The company's former parent expects to settle a dispute over retained environmental liabilities.
- PR Newswire
Chemours Announces Second Quarter Dividend
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the second quarter of 2020. The dividend will be paid on June 15, 2020 to stockholders of record as of the close of business on May 15, 2020.
- Moody's
DuPont de Nemours, Inc. -- Moody's assigns Baa1 to DuPont's new notes; outlook stable
Moody's Investors Service, ("Moody's") assigned Baa1 rating to DuPont de Nemours, Inc.'s (DuPont's) new senior unsecured notes maturing in 2023. "DuPont's new issuance will provide the financial flexibility to refinance their upcoming November maturity while maintaining a solid level of cash cushion during the coronavirus pandemic," said John Rogers, Senior Vice President at Moody's and lead analyst on DuPont.
- Moody's
Chemours Company, (The) -- Moody's downgrades Chemours to Ba3, Outlook negative
Moody's Investors Service ("Moody's"), downgraded The Chemours Company's (Chemours) ratings, including the CFR to Ba3 from Ba2, the secured bank facilities to Ba1 from Baa3, and the senior unsecured rating to B1 from Ba3. The outlook on the ratings remains negative, reflecting the heightened and growing level of litigation risk stemming from actions filed by states, environmental regulators, water municipalities and private plaintiffs associated with perfluorochemicals (or PFAS), a family of chemicals used for decades to process a wide range of fluoropolymers. "The downgrade reflects the growing PFAS case load, its impact on the potential ultimate liability, and other adverse developments associated with PFAS litigation" according to Joseph Princiotta, Senior Vice President at Moody's. " The downgrade also reflects profit pressures in flouroproducts and TiO2 and the resulting stress to metrics and cash flow this year," Princiotta added.
- Simply Wall St.
Easy Come, Easy Go: How Chemours (NYSE:CC) Shareholders Got Unlucky And Saw 76% Of Their Cash Evaporate
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
- PR Newswire
Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The company will conduct its first quarter 2020 webcast conference call on Wednesday, May 6, 2020 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.
- PR Newswire
The Chemours Company Moves Annual Meeting of Shareholders to Virtual-Only Format
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced that the format of this year's Annual Meeting of Shareholders (the "Annual Meeting") has been changed from in-person to virtual-only.
![McIntyre Partnerships 1Q20 Commentary: Long Chemours [Analysis]](https://s.yimg.com/uu/api/res/1.2/pRfRnD7RGnaPA2h8Vavdfg--~B/Zmk9ZmlsbDtoPTEyMztweW9mZj0wO3E9ODA7dz0yMjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en-us/insidermonkey.com/210da56a09b428bf8db40db2a117bf13)
